The global ablation devices market size was $3,047 million in 2015 and is estimated to reach $6,658 million by 2022, growing a CAGR of 11.7% from 2016 to 2022.
Ablation therapies can be used for the treatment of various diseases across several medical domains such as ophthalmology, cancer, gynecology, and cardiovascular. Being a minimally invasive procedure, it is less painful than conventional surgical operations, leading to shorter recovery time. In addition, it causes very little damage to the surrounding tissues. Even though it lowers the side effects, it has some disadvantages as well. For instance, large and bulky tissues, such as bone and neck nodules, cannot be treated with ablation. Besides, the availability of ablation treatment in remote locations is quite restricted.
Download PDF Report Sample @https://www.alliedmarketresearch.com/request-sample/1749
• St. Jude Medical, Inc.
• Medtronic plc,
• Boston Scientific Corporation
• AngioDynamics, Inc.,
• AtriCure, Inc.
• Conmed Corporation
• Olympus Corporation
• Smith & Nephew plc
• BTG plc
• Johnson & Johnson.
Sudden cardiac arrest is the leading cause of death in U.S., responsible for about 300,000 deaths per year. As per a research by St. Jude Medical, Inc., in 2015, there were about 250,000 catheter ablations performed in U.S. alone, whereas the global estimate was about 990,000. Electrophysiology employs catheter ablation to destroy abnormal heart tissues that cause irregular heart rhythms or cardiac arrhythmia. Radiofrequency and cryoablation are the most widely used ablation catheters and are expected to proliferate in the future. In addition, the number of ablation procedures performed for the treatment of atrial fibrillation are expected to increase substantially in the future.
The ablation devices market is growing at the steady pace due to the growth in incidence of cardiac diseases such as atrial fibrillation (AF), atrial flutter, and cardiac arrhythmias. Hence, different mid-to-large sized companies have augmented research and development (R&D) investments in this market. Moreover, even smaller companies have shifted their focus and increased their R&D activities, which has led to a surge in product developments (approvals & launches), and in turn contributing to the growth of ablation devices industry. For instance, Medtronic launched the new Barrx 360 Express radiofrequency ablation balloon catheter in April 2016, which is a self-adjusting circumferential RFA catheter to remove diseased tissues. This catheter is anticipated to aid the treatment of Barretts esophagus.
KEY BENEFITS FOR STAKEHOLDERS:
• The report provides an extensive analysis of the current trends and highlights the market potential from 2014 to 2022.
• The market scenario is comprehensively analyzed with respect to the technology, application, function, and procedure.
• Comprehensive analysis of the patents and clinical trials is provided to determine the prevailing opportunities.
• Recent developments, key manufacturers, and market shares are listed in this report to analyze the competitive scenario of the market.
• In-depth analysis of the market based on geography gives an understanding of the regional market, which assists in strategic business planning.
Make an Enquiry before Buying @https://www.alliedmarketresearch.com/purchase-enquiry/1749